Enter your contact details & our Business Development
expert will circle back to address your request!
Published on 04/03/2021| Code: GINR42221| Category: Information Technology| Total Pages: 112
The Personalized Medicine (PM) Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Personalized Medicine (PM) Solution size is estimated to be USD XX million in 2026 from USD XX million in 2020, with a change XX% between 2020 and 2021. The global Personalized Medicine (PM) Solution market size is expected to grow at a CAGR of XX% for the next five years.
Market segmentation
Personalized Medicine (PM) Solution market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Personalized Diagnostics
Personalized Therapies
Personalized Nutrition & Wellness
Market segment by Application, can be divided into
Oncology
Neurosciences
Immunology
Respiratory
Others
Market segment by players, this report covers
2bPrecise
OneOme
TIGAR Health- IR2Dx
Kailos Genetics
Syapse Inc
Karius
Astarte Medical
Fabric Genomics, INC.
Orion Health
2B Precise
Fabric Genomics
Pfizer
Gene 42
IBM Watson Health
Philips Healthcare
Medtronic
Nanthealth
Navican
N-of-One
PierianDx
Sunquest Information System
Tempus
Novartis
Translational Software
Biocrates Life Sciences AG
Nanostring Technologies
Thermo Fisher Scientific
Quest Diagnostics Incorporated
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Personalized Medicine (PM) Solution product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Personalized Medicine (PM) Solution, with revenue, gross margin and global market share of Personalized Medicine (PM) Solution from 2019 to 2021.
Chapter 3, the Personalized Medicine (PM) Solution competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Personalized Medicine (PM) Solution market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Personalized Medicine (PM) Solution research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Personalized Medicine (PM) Solution
1.2 Classification of Personalized Medicine (PM) Solution by Type
1.2.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Personalized Medicine (PM) Solution Revenue Market Share by Type in 2020
1.2.3 Personalized Diagnostics
1.2.4 Personalized Therapies
1.2.5 Personalized Nutrition & Wellness
1.3 Global Personalized Medicine (PM) Solution Market by Application
1.3.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Global Personalized Medicine (PM) Solution Market Size & Forecast
1.5 Global Personalized Medicine (PM) Solution Market Size and Forecast by Region
1.5.1 Global Personalized Medicine (PM) Solution Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Personalized Medicine (PM) Solution Market Size by Region, (2016-2021)
1.5.3 North America Personalized Medicine (PM) Solution Market Size and Prospect (2016-2026)
1.5.4 Europe Personalized Medicine (PM) Solution Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Personalized Medicine (PM) Solution Market Size and Prospect (2016-2026)
1.5.6 South America Personalized Medicine (PM) Solution Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Personalized Medicine (PM) Solution Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Personalized Medicine (PM) Solution Market Drivers
1.6.2 Personalized Medicine (PM) Solution Market Restraints
1.6.3 Personalized Medicine (PM) Solution Trends Analysis
2 Company Profiles
2.1 2bPrecise
2.1.1 2bPrecise Details
2.1.2 2bPrecise Major Business
2.1.3 2bPrecise Personalized Medicine (PM) Solution Product and Solutions
2.1.4 2bPrecise Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 2bPrecise Recent Developments and Future Plans
2.2 OneOme
2.2.1 OneOme Details
2.2.2 OneOme Major Business
2.2.3 OneOme Personalized Medicine (PM) Solution Product and Solutions
2.2.4 OneOme Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 OneOme Recent Developments and Future Plans
2.3 TIGAR Health- IR2Dx
2.3.1 TIGAR Health- IR2Dx Details
2.3.2 TIGAR Health- IR2Dx Major Business
2.3.3 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Product and Solutions
2.3.4 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 TIGAR Health- IR2Dx Recent Developments and Future Plans
2.4 Kailos Genetics
2.4.1 Kailos Genetics Details
2.4.2 Kailos Genetics Major Business
2.4.3 Kailos Genetics Personalized Medicine (PM) Solution Product and Solutions
2.4.4 Kailos Genetics Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Kailos Genetics Recent Developments and Future Plans
2.5 Syapse Inc
2.5.1 Syapse Inc Details
2.5.2 Syapse Inc Major Business
2.5.3 Syapse Inc Personalized Medicine (PM) Solution Product and Solutions
2.5.4 Syapse Inc Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Syapse Inc Recent Developments and Future Plans
2.6 Karius
2.6.1 Karius Details
2.6.2 Karius Major Business
2.6.3 Karius Personalized Medicine (PM) Solution Product and Solutions
2.6.4 Karius Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Karius Recent Developments and Future Plans
2.7 Astarte Medical
2.7.1 Astarte Medical Details
2.7.2 Astarte Medical Major Business
2.7.3 Astarte Medical Personalized Medicine (PM) Solution Product and Solutions
2.7.4 Astarte Medical Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Astarte Medical Recent Developments and Future Plans
2.8 Fabric Genomics, INC.
2.8.1 Fabric Genomics, INC. Details
2.8.2 Fabric Genomics, INC. Major Business
2.8.3 Fabric Genomics, INC. Personalized Medicine (PM) Solution Product and Solutions
2.8.4 Fabric Genomics, INC. Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Fabric Genomics, INC. Recent Developments and Future Plans
2.9 Orion Health
2.9.1 Orion Health Details
2.9.2 Orion Health Major Business
2.9.3 Orion Health Personalized Medicine (PM) Solution Product and Solutions
2.9.4 Orion Health Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Orion Health Recent Developments and Future Plans
2.10 2B Precise
2.10.1 2B Precise Details
2.10.2 2B Precise Major Business
2.10.3 2B Precise Personalized Medicine (PM) Solution Product and Solutions
2.10.4 2B Precise Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 2B Precise Recent Developments and Future Plans
2.11 Fabric Genomics
2.11.1 Fabric Genomics Details
2.11.2 Fabric Genomics Major Business
2.11.3 Fabric Genomics Personalized Medicine (PM) Solution Product and Solutions
2.11.4 Fabric Genomics Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Fabric Genomics Recent Developments and Future Plans
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Personalized Medicine (PM) Solution Product and Solutions
2.12.4 Pfizer Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Pfizer Recent Developments and Future Plans
2.13 Gene 42
2.13.1 Gene 42 Details
2.13.2 Gene 42 Major Business
2.13.3 Gene 42 Personalized Medicine (PM) Solution Product and Solutions
2.13.4 Gene 42 Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Gene 42 Recent Developments and Future Plans
2.14 IBM Watson Health
2.14.1 IBM Watson Health Details
2.14.2 IBM Watson Health Major Business
2.14.3 IBM Watson Health Personalized Medicine (PM) Solution Product and Solutions
2.14.4 IBM Watson Health Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 IBM Watson Health Recent Developments and Future Plans
2.15 Philips Healthcare
2.15.1 Philips Healthcare Details
2.15.2 Philips Healthcare Major Business
2.15.3 Philips Healthcare Personalized Medicine (PM) Solution Product and Solutions
2.15.4 Philips Healthcare Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Philips Healthcare Recent Developments and Future Plans
2.16 Medtronic
2.16.1 Medtronic Details
2.16.2 Medtronic Major Business
2.16.3 Medtronic Personalized Medicine (PM) Solution Product and Solutions
2.16.4 Medtronic Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Medtronic Recent Developments and Future Plans
2.17 Nanthealth
2.17.1 Nanthealth Details
2.17.2 Nanthealth Major Business
2.17.3 Nanthealth Personalized Medicine (PM) Solution Product and Solutions
2.17.4 Nanthealth Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Nanthealth Recent Developments and Future Plans
2.18 Navican
2.18.1 Navican Details
2.18.2 Navican Major Business
2.18.3 Navican Personalized Medicine (PM) Solution Product and Solutions
2.18.4 Navican Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Navican Recent Developments and Future Plans
2.19 N-of-One
2.19.1 N-of-One Details
2.19.2 N-of-One Major Business
2.19.3 N-of-One Personalized Medicine (PM) Solution Product and Solutions
2.19.4 N-of-One Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 N-of-One Recent Developments and Future Plans
2.20 PierianDx
2.20.1 PierianDx Details
2.20.2 PierianDx Major Business
2.20.3 PierianDx Personalized Medicine (PM) Solution Product and Solutions
2.20.4 PierianDx Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 PierianDx Recent Developments and Future Plans
2.21 Sunquest Information System
2.21.1 Sunquest Information System Details
2.21.2 Sunquest Information System Major Business
2.21.3 Sunquest Information System Personalized Medicine (PM) Solution Product and Solutions
2.21.4 Sunquest Information System Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 Sunquest Information System Recent Developments and Future Plans
2.22 Tempus
2.22.1 Tempus Details
2.22.2 Tempus Major Business
2.22.3 Tempus Personalized Medicine (PM) Solution Product and Solutions
2.22.4 Tempus Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.22.5 Tempus Recent Developments and Future Plans
2.23 Novartis
2.23.1 Novartis Details
2.23.2 Novartis Major Business
2.23.3 Novartis Personalized Medicine (PM) Solution Product and Solutions
2.23.4 Novartis Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.23.5 Novartis Recent Developments and Future Plans
2.24 Translational Software
2.24.1 Translational Software Details
2.24.2 Translational Software Major Business
2.24.3 Translational Software Personalized Medicine (PM) Solution Product and Solutions
2.24.4 Translational Software Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.24.5 Translational Software Recent Developments and Future Plans
2.25 Biocrates Life Sciences AG
2.25.1 Biocrates Life Sciences AG Details
2.25.2 Biocrates Life Sciences AG Major Business
2.25.3 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Product and Solutions
2.25.4 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.25.5 Biocrates Life Sciences AG Recent Developments and Future Plans
2.26 Nanostring Technologies
2.26.1 Nanostring Technologies Details
2.26.2 Nanostring Technologies Major Business
2.26.3 Nanostring Technologies Personalized Medicine (PM) Solution Product and Solutions
2.26.4 Nanostring Technologies Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.26.5 Nanostring Technologies Recent Developments and Future Plans
2.27 Thermo Fisher Scientific
2.27.1 Thermo Fisher Scientific Details
2.27.2 Thermo Fisher Scientific Major Business
2.27.3 Thermo Fisher Scientific Personalized Medicine (PM) Solution Product and Solutions
2.27.4 Thermo Fisher Scientific Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.27.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.28 Quest Diagnostics Incorporated
2.28.1 Quest Diagnostics Incorporated Details
2.28.2 Quest Diagnostics Incorporated Major Business
2.28.3 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Product and Solutions
2.28.4 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021)
2.28.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Personalized Medicine (PM) Solution Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Personalized Medicine (PM) Solution Players Market Share
3.2.2 Top 10 Personalized Medicine (PM) Solution Players Market Share
3.2.3 Market Competition Trend
3.3 Personalized Medicine (PM) Solution Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Personalized Medicine (PM) Solution Revenue and Market Share by Type (2016-2021)
4.2 Global Personalized Medicine (PM) Solution Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Personalized Medicine (PM) Solution Revenue Market Share by Application (2016-2021)
5.2 Personalized Medicine (PM) Solution Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Personalized Medicine (PM) Solution Revenue by Type (2016-2026)
6.2 North America Personalized Medicine (PM) Solution Revenue by Application (2016-2026)
6.3 North America Personalized Medicine (PM) Solution Market Size by Country
6.3.1 North America Personalized Medicine (PM) Solution Revenue by Country (2016-2026)
6.3.2 United States Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
6.3.3 Canada Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
6.3.4 Mexico Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Personalized Medicine (PM) Solution Revenue by Type (2016-2026)
7.2 Europe Personalized Medicine (PM) Solution Revenue by Application (2016-2026)
7.3 Europe Personalized Medicine (PM) Solution Market Size by Country
7.3.1 Europe Personalized Medicine (PM) Solution Revenue by Country (2016-2026)
7.3.2 Germany Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
7.3.3 France Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
7.3.5 Russia Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
7.3.6 Italy Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Type (2016-2026)
8.2 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Application (2016-2026)
8.3 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region
8.3.1 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Region (2016-2026)
8.3.2 China Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
8.3.3 Japan Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
8.3.4 South Korea Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
8.3.5 India Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
8.3.7 Australia Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Personalized Medicine (PM) Solution Revenue by Type (2016-2026)
9.2 South America Personalized Medicine (PM) Solution Revenue by Application (2016-2026)
9.3 South America Personalized Medicine (PM) Solution Market Size by Country
9.3.1 South America Personalized Medicine (PM) Solution Revenue by Country (2016-2026)
9.3.2 Brazil Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
9.3.3 Argentina Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Type (2016-2026)
10.2 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Application (2016-2026)
10.3 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country
10.3.1 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Country (2016-2026)
10.3.2 Turkey Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
10.3.4 UAE Personalized Medicine (PM) Solution Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Please fill form below:
USA: +1(929)-450-2887
USA: +1(650)-666-4592
99 WALL STREET #2124 NEW YORK, NY 10005